figshare + Loughborough Research Repository2026 · Astronomical catalogue
<b>PLURIpanel for Quantitative Analysis of Stemness in Pluripotency and Cancer</b><p dir="ltr">Data was generated by staining established cell lines and patient samples with a custom antibody panel (PLURIpanel), using CyTOF (mass cytometry) to profile stem cell marker expression.</p><p dir="ltr">hPSCs.fcs H7 (WiCell Research Institute, Madison, WI)</p><p dir="ltr">hPSCs BMP4 72h.fcs H7 (WiCell Research Institute, Madison, WI), BMP-4 (R&D, CF 314-BP-010) treatment was applied at
figshare2026 · Astronomical catalogue
First-line PD-1 inhibitor plus chemotherapy versus chemotherapy alone in HER2-negative advanced gastric or gastro-oesophageal junction cancer with PD-L1 CPS below 5: a multicentre retrospective cohort study<p dir="ltr">In advanced HER2-negative gastric or gastro-oesophageal junction cancer with PD-L1 CPS below 5, adding PD-1 inhibition to first-line chemotherapy was associated with longer survival but more severe toxicity.</p>
figshare2026 · Astronomical catalogue
Data and Supplementary Materials for KRAS, BRCA, and TP53 Mutations as Prognostic Biomarkers in Pancreatic Cancer: A Systematic Review and Meta-Analysis<p dir="ltr">KRAS, BRCA, and TP53 Mutations as Prognostic Biomarkers in Pancreatic Cancer: A Systematic Review and Meta-Analysis</p><p dir="ltr"><b>1. General Information</b></p><ul><li>Study Title: KRAS, BRCA, and TP53 Mutations as Prognostic Biomarkers in Pancreatic Cancer: A Systematic Review and Meta-Analysis of Survival Outcomes</li><li><b>Corresponding Author:</b> Wahby Mohammed Babaresh</li